Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . November 5th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Antiviral Therapy - Hepatitis B Interferon Nonresponders Improve Upon Sequential Dosing
Vaccine Efficacy - Hepatitis B Vaccine Response Falls Short In Youth, Those With HIV
Carcinogenesis - Epstein-Barr Virus Not A Factor In American Cases Of Primary Liver Cancer
DNA Cloning - Protein Could Be Important Hepatitis B Therapy For Humans
Pathology - Fibrosis Markers Reflect Liver Appearance After Hepatitis C Virus Therapy
Disease Risk Factors - Group Studies Estrogen Receptors And Cancer Prevention In Chronic Hepatitis C
Drug Development - Immune-Regulating Hormone Enters Clinical Trials
Drug Safety - Acetaminophen Not Linked To Liver Injury In Alcoholics
Ethnic Differences - Study To Examine Race And Response To Hepatitis C Therapy
Hepatitis C Virus - Phase II Trial Initiated By Ribozyme Pharmaceuticals
Transfection - Baculovirus Extends Study Of Gene Transfer In Hepatocytes
Transplantation - Gene Transfer Circumnavigates Usual Problems With Liver Cell Transplants
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
